No Advantage of Expanded Polytetrafluoroethylene and Fluorinated Ethylene Propylene-Covered Stents over Uncovered Nitinol Stents for Percutaneous Palliation of Malignant Infrahilar Biliary Obstruction: Results of a Single-Center Prospective Randomized Trial.

Abstract

PURPOSE:

To prove that covered stents are more efficacious than uncovered stents regarding patency, safety, enabling of chemotherapy, and survival in percutaneous palliation of malignant infrahilar biliary obstruction.

MATERIALS AND METHODS:

After failed endoscopic treatment, 154 patients with obstructive jaundice caused by unresectable infrahilar malignancy were randomly allocated to receive an expanded polytetrafluoroethylene and fluorinated ethylene propylene-covered or an uncovered nitinol stent. Occlusion rate, patency, and survival were assessed. Safety and clinical success in terms of chemotherapy were compared.

RESULTS:

Three patients were excluded post hoc. Fifteen patients died within 7 d and were excluded from patency analysis. Occlusion rates were 32% (21 of 66) for covered and 29% (20 of 70) for uncovered stents (P = .7). Estimated median patency durations were 308 d (95% confidence interval [CI], 178-438 d) for covered and 442 d (95% CI, 172-712 d) for uncovered stents (P = .1). Serious adverse events (P = 1.0) and 30-day mortality (P = .5) were equivalent between groups. At hospital discharge, median bilirubin reduction of 8 mg/dL was found in both groups (P < .001). In the covered stent group, 35 patients (48%) received palliative chemotherapy, vs 29 (37%) in the uncovered stent group (P = .2). Estimated median survival times were 96 days (95% CI, 68-124 d) with covered stents and 75 days (95% CI, 42-108 d) with uncovered stents (P = .6).

CONCLUSIONS:

In malignant infrahilar biliary obstruction not amenable to endoscopy, no improvement in patency or survival with percutaneously placed covered stents could be confirmed. Covered and uncovered stent types exhibit similar safety profiles and clinical success rates.

• Authors: Elisabeth Dhondt, Peter Vanlangenhove, Marc De Man, Lynn Huyck, Luc Defreyne
• Journal: Journal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 31 Issue 1 Pg. 82-92 (Jan 2020) ISSN: 1535-7732 [Electronic] United States
• PMID: 31627908 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
• Copyright: Copyright © 2019 SIR. Published by Elsevier Inc. All rights reserved.

Chemical References

• Alloys
• Coated Materials, Biocompatible
• fluorinated ethylene propylene
• nitinol
• Polytetrafluoroethylene

Topics

• Adult
• Aged
• Aged, 80 and over
• Alloys
• Belgium
• Cholestasis (diagnostic imaging, etiology, mortality, therapy)
• Coated Materials, Biocompatible
• Digestive System Neoplasms (complications, diagnostic imaging, drug therapy, mortality)
• Drainage (adverse effects, instrumentation, mortality)
• Female
• Humans
• Male
• Middle Aged
• Palliative Care
• Polytetrafluoroethylene (analogs & derivatives)
• Prospective Studies
• Prosthesis Design
• Risk Factors
• Stents
• Time Factors
• Treatment Outcome
• Young Adult